Biolase (BIOL) Tops Q3 EPS by 2c

Biolase (NASDAQ: BIOL) reported Q3 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $12.7 million versus the consensus estimate of $11.7 million.

For earnings history and earnings-related data on Biolase (BIOL) click here.

You May Also Be Interested In

• Netflix climbs following Ackman stake, up 1.8%
• Telesat Corporation (TSAT) Misses Q2 EPS by 1006c
• Aebi Schmidt Holding AG (AEBI) Reports Q2 results; offers guidance